Soluble IL‐2 receptor levels support diagnosis of sarcoidosis‐like reaction in melanoma patients on immunotherapy – a diagnostic algorithm based on a single center retrospective study
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2025
DOI: 10.1111/ddg.15727 ↗Kurz gefasst
Fachartikel in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2025. Verfasst von Philipp Gussek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology, University Medical Center Leipzig, Leipzig, Germany. Hauptthemen laut MEDLINE: Melanoma, Receptors, Interleukin-2, Sarcoidosis, Skin Neoplasms. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Objectives Drug‐induced sarcoidosis‐like reaction (DISR) is an adverse event with emerging importance during immune checkpoint inhibitor (ICI) treatment in melanoma patients. Its reported frequency varies widely, making accurate diagnosis crucial. Distinguishing DISR from tumor progression is challenging, and misdiagnosis may lead to detrimental treatment changes. Thus, reliable diagnostic markers complementing histopathology as well as a diagnostic algorithm are needed. Patients and methods This single‐center retrospective study, conducted at the University Medical Center in Leipzig, Germany, from 09/2019 to 06/2021, assessed DISR prevalence in melanoma patients treated with ICI for metastatic melanoma. We examined clinical characteristics, radiology, histopathology, and serum parameters.
Results
From a total of 177 patients 19 patients were suspicious for DISR. Of those, DISR was diagnosed in seven patients. In a further nine patients DISR was highly probable based on radiological findings and noticeably increased soluble interleukin‐2‐receptor (sIL2R) levels, resulting in DISR prevalence of 9%. No patient required permanent discontinuation of ICI due to DISR.
Conclusions
In melanoma patients receiving ICI, DISR is common. Histological confirmation through mediastinoscopy or pulmonary wedge resection offers the highest diagnostic accuracy. When histology is not available, sIL2R levels can aid diagnosis. We propose an algorithm to distinguish DISR from tumor progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Allergology, University Medical Center Leipzig, Leipzig, Germany.
- Department of Diagnostic and Interventional Radiology, University Medical Center Leipzig, Leipzig, Germany.
- Department for Interventional Radiology, Helios Park-Klinikum, Leipzig, Germany.
ORCID-Profile: Mirjana Ziemer
Zitieren
APA
Gussek, P., Mentzel, J., Ablefoni, M., & Ziemer, M. (2025). Soluble IL‐2 receptor levels support diagnosis of sarcoidosis‐like reaction in melanoma patients on immunotherapy – a diagnostic algorithm based on a single center retrospective study. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15727
Vancouver
Gussek P, Mentzel J, Ablefoni M, Ziemer M. Soluble IL‐2 receptor levels support diagnosis of sarcoidosis‐like reaction in melanoma patients on immunotherapy – a diagnostic algorithm based on a single center retrospective study. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2025. doi:10.1111/ddg.15727
BibTeX
@article{Gussek2025,
author = {Gussek, Philipp and Mentzel, Julia and Ablefoni, Maxime and Ziemer, Mirjana},
title = {Soluble IL‐2 receptor levels support diagnosis of sarcoidosis‐like reaction in melanoma patients on immunotherapy – a diagnostic algorithm based on a single center retrospective study},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2025},
doi = {10.1111/ddg.15727}
}
EUVIMED